Výsledky vyhledávání - "Charles L. Roche"

Supplemental Figure 2 from Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma

Autor: Eric C. Kauffman, Charles L. Roche, Michael Petroziello, Craig Hendler, Thomas Schwaab, Kristopher M. Attwood, Christine Murekeyisoni, Daniel Abbotoy, Terrance T. Creighton, Shervin Badkhshan, Bo Xu, Jay Amin

Representative CT imaging of CD117(-) RO/ChRCC tumors using an early contrast phase. (A) This representative CD117(-) RO tumor has relative hyperenhancement (tumor:cortex PEER 0.79) that is similar to CD117(+) RO tumors; (B) Thisrepresentative CD117(

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::324924f9467d23e03cc65be89b7e963a
https://doi.org/10.1158/1078-0432.22474721

Zobrazit plný text záznamu

Supplemental Figure 1 from Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma

Non-PEER CT peak signal intensity/enhancement values in RO versus ChRCC tumors according to CD117 expression. (A) Net peak enhancement using the delayed/excretory contrast phase relative to the unenhanced phase; (B) Absolute peak signal intensity usi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25fc0cb257e335488c74a2cabdf5a4ea
https://doi.org/10.1158/1078-0432.22474724

Zobrazit plný text záznamu

Data from Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma

Purpose: The diagnostic differential for CD117/KIT(+) oncocytic renal tumor biopsies is limited to benign renal oncocytoma versus chromophobe renal cell carcinoma (ChRCC); however, further differentiation is often challenging and requires surgical re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30d2d213daebc98faffd6e673e61e54c
https://doi.org/10.1158/1078-0432.c.6528884.v1

Zobrazit plný text záznamu

Supplemental Table 1 from Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma

Eosinophilia in ChRCC tumors

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50e37693843e1f0bd79ac624db325245
https://doi.org/10.1158/1078-0432.22474712

Zobrazit plný text záznamu

Supplemental Figure 3 from Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma

Representative examples of CD117 and CK immunostaining in ChRCC and RO tumors. Representative staining images are shown at 100X magnification. (A-B) Hematoxylin & Eosin staining for (A) ChRCC and (B) RO. (C-D) Typical strong/diffuse CD117 staining in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d456e0f5052e36dd9aaafa35325cf58
https://doi.org/10.1158/1078-0432.22474715

Zobrazit plný text záznamu

Stability of renal parenchymal volume and function during active surveillance of renal oncocytoma patients

Autor: Arun R. Menon, Amandip Cheema, Surui Hou, Kristopher M. Attwood, Tashionna White, Gaybrielle James, Bo Xu, Michael Petroziello, Charles L. Roche, Sergei Kurenov, Eric C. Kauffman

Publikováno v: Urologic Oncology: Seminars and Original Investigations. 41:208.e15-208.e23

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::53a39e5a5eccedaadc18786c27a4b373
https://doi.org/10.1016/j.urolonc.2023.01.006

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání